Italia markets closed
FTSE MIB
33.154,05 -32,84 (-0,10%) Dow Jones
39.118,86 -45,20 (-0,12%) Nasdaq
17.732,60 -126,08 (-0,71%) Nikkei 225
39.583,08 +241,54 (+0,61%) Petrolio
81,46 -0,28 (-0,34%) Bitcoin EUR
57.376,94 +426,84 (+0,75%)
PACB Dec 2024 6.000 put
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
In data: 03:46PM EDT. Mercato aperto.
| Chiusura precedente | 4,6200 |
| Aperto | 4,6200 |
| Denaro | 4,4000 |
| Domanda | 5,2000 |
| Prezzo d'esercizio | 6,00 |
| Scadenza | 2024-12-20 |
| Min-Max giorno | 4,6200 - 4,6200 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | N/D |
GlobeNewswirePacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platformsMENLO PARK, Calif. and STAMFORD, Conn., Aug. 07, 2023 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions and GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced a research collaboration with the University of Washington to study the capabilities of HiFi long
© 2024 Yahoo. Tutti i diritti riservati.